We productively manage relationships with our investors, shareholders and analysts, and promote the attractiveness of our stock through range of activities.
- The Group's total business volume increased by 18% compared to Q1 2024, reaching EUR 553.7 million, primarily driven by a rise in gross written premium.
- The Group's earnings before tax rose by 25% to EUR 54.3 million, while net earnings increased by 26% to EUR 46.1 million.
- The Group reaffirms its annual profit guidance for 2025, taking into account the expected business conditions for the remainder of the year.
- The combined ratio for the Non-Life and Health segments stood at 88.5%, remaining at a comparably low level to the previous year. The new business margin of the Life segment stood at a favourable 11.7% (Q1 2024: 14.9%).
- The Group's capitalisation remains within the target range of 200–250%.
More in the press release.